Analysts Viewpoint
Days-to-cover ratio for APLS surges to 6.88 due to rise in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Apellis Pharmaceuticals Inc revealed its Chief Executive Officer Francois Cedric unloaded Company’s shares for reported $0.4 million
In a filing, Apellis Pharmaceuticals Inc revealed its Chief Executive Officer Francois Cedric unloaded Company’s shares for reported $0.4 million